Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
Condition(s):Pheochromocytoma; ParagangliomaLast Updated:October 7, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Pheochromocytoma; ParagangliomaLast Updated:October 7, 2022Recruiting
Condition(s):Breast Cancer; Ovarian Cancer; Breast Neoplasms; Ovarian Neoplasms; BRCA Mutation; HER2-positive Breast Cancer; HER2-negative Breast Cancer; HER-2 Protein OverexpressionLast Updated:July 12, 2023Enrolling by invitation
Condition(s):Pheochromocytoma; ParagangliomaLast Updated:January 6, 2021Completed
Condition(s):Adenoid Cystic CarcinomaLast Updated:November 28, 2017Completed
Condition(s):Healthy VolunteersLast Updated:September 21, 2009Completed
Condition(s):Carcinoma, Renal CellLast Updated:June 5, 2019Completed
Condition(s):Hepatocellular CarcinomaLast Updated:December 12, 2019Completed
Condition(s):Healthy VolunteersLast Updated:August 4, 2009Completed
Condition(s):Healthy VolunteersLast Updated:November 16, 2009Completed
Condition(s):Healthy VolunteerLast Updated:April 22, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.